Antibody‐positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series
Brain and Behavior · 2024
DOI: 10.1002/brb3.3534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2024. Verfasst von Sonja Kosek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Paraneoplastic Syndromes, Nervous System, Autoantibodies, Encephalitis, Hashimoto Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Swedish Brain Foundation, Centre for Clinical Research Region Värmland.
Abstract (Originalsprache)
Objective
This study aimed to explore the clinical characteristics and temporal disease course of patients with autoimmune encephalitis (AE) and paraneoplastic neurological syndrome (PNS) in Sweden.
Methods
Thirty‐seven antibody‐positive AE and PNS cases were identified in the Healthcare region Mid Sweden between 2015 and 2019. Clinical data were collected through a retrospective review of electronic health records. Patients were divided into three subgroups based on antibody type: neuronal surface antibodies (NSAbs), onconeural antibodies, and anti‐GAD65 antibodies.
Results
Nineteen patients had NSAbs, 11 onconeural antibodies, and seven anti‐GAD65 antibodies. Anti‐LGI1 and anti‐NMDAR were the most frequently detected NSAbs, with anti‐NMDAR cases having an older‐than‐expected age distribution (median age 40, range 17–72). Only 11 of 32 (30%) of patients had findings suggesting encephalitis on initial MRI, but 28 of 31 (90%) had pathological findings on initial cerebrospinal fluid analysis. All patients but one had abnormal EEG findings. Median time to immunotherapy was comparable among the three subgroups, whereas patients with anti‐LGI1, anti‐CASPR2, and anti‐IgLON5 had an eightfold longer time to immunotherapy than anti‐NMDAR and anti‐GABA‐B ( p = .0016). There was a seasonal variation in onset for patients with non‐tumor‐related NSAbs and anti‐GAD65 antibodies, with most patients (72%) falling ill in spring or summer.
Conclusion
Swedish patients with AE and PNS had similar clinical characteristics as previously described cohorts from other geographical regions except for anti‐NMDAR encephalitis, with older onset than expected. The onset of non‐tumor‐related AE occurred predominantly in the warm seasons, and AE with a more insidious onset was associated with delayed treatment initiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
- Centre for Clinical Research and Education, Karlstad, Sweden.
ORCID-Profile: Sonja Kosek, Anna Rostedt Punga
Förderung
- Vetenskapsrådet
- Swedish Brain Foundation
- Centre for Clinical Research Region Värmland
- Svenska Sällskapet för Medicinsk Forskning
- Marianne and Marcus Wallenberg Foundation
Zitieren
APA
Kosek, S., Burman, J., & Punga, A. R. (2024). Antibody‐positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series. Brain and Behavior. https://doi.org/10.1002/brb3.3534
Vancouver
Kosek S, Burman J, Punga AR. Antibody‐positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series. Brain and Behavior. 2024. doi:10.1002/brb3.3534
BibTeX
@article{Kosek2024,
author = {Kosek, Sonja and Burman, Joachim and Punga, Anna Rostedt},
title = {Antibody‐positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series},
journal = {Brain and Behavior},
year = {2024},
doi = {10.1002/brb3.3534}
}
EUVIMED